Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement of Pfizer Inc. Securities Litigation

The following statement is being issued by Robbins Geller Rudman & Dowd LLP regarding the Pfizer Inc. Securities Litigation:

YOU ARE HEREBY NOTIFIED, pursuant to an Order of the United States District Court for the Southern District of New York, that a hearing will be held on July 30, 2015, at 2:30 p.m., before the Honorable Alvin K. Hellerstein, United States District Judge, at the United States District Court for the Southern District of New York, Daniel Patrick Moynihan United States Courthouse, 500 Pearl Street, Courtroom 14D, New York, NY 10007-1312, for the purpose of determining: (1) whether the proposed settlement of the claims in the Litigation for the principal amount of $400,000,000.00, plus interest, should be approved by the Court as fair, just, reasonable, and adequate; (2) whether a Final Judgment and Order of Dismissal with Prejudice should be entered by the Court dismissing the Litigation with prejudice; (3) whether the Plan of Allocation is fair, reasonable, and adequate and should be approved; and (4) whether the application of Lead Counsel for the payment of attorneys’ fees and expenses and Lead Plaintiff’s and Class Representative Mary K. Jones’ expenses in connection with this Litigation should be approved.

IF YOU PURCHASED DOMESTICALLY OR PURCHASED ON DOMESTIC EXCHANGES ANY OF THE COMMON STOCK OF PFIZER DURING THE PERIOD JANUARY 19, 2006 THROUGH JANUARY 23, 2009, INCLUSIVE, YOUR RIGHTS MAY BE AFFECTED BY THE SETTLEMENT OF THIS LITIGATION. If you have not received a detailed Notice of Proposed Settlement of Class Action (“Notice of Proposed Settlement”) and a copy of the Proof of Claim and Release form, you may obtain copies by writing to Pfizer Litigation, Claims Administrator, c/o Gilardi & Co. LLC, P.O. Box 808003, Petaluma, CA 94975-8003, or on the internet at www.pfizerincsecuritieslitigation.com. If you are a Class Member, in order to share in the distribution of the Net Settlement Fund, you must submit a Proof of Claim and Release by mail (postmarked no later than July 30, 2015) or submitted electronically no later than July 30, 2015, establishing that you are entitled to recovery.

If you are a Class Member and you desire to be excluded from the Class, you must submit a request for exclusion such that it is postmarked no later than May 21, 2015, in the manner and form explained in the detailed Notice of Proposed Settlement, referred to above. If you previously requested exclusion from the Class pursuant to the Notice of Pendency of Class Action dated November 17, 2014 (“Notice of Pendency”) and still want to be excluded, you need not request exclusion again. All Members of the Class who do not timely and validly request exclusion from the Class in response to the Notice of Proposed Settlement or did not previously request exclusion in response to the Notice of Pendency will be bound by any judgment entered in the Litigation pursuant to the Stipulation.

Any objection to the settlement, the Plan of Allocation of settlement proceeds, or the fee and expense application must be mailed to each of the following recipients, postmarked no later than May 21, 2015:

PLEASE DO NOT CONTACT THE COURT OR THE CLERK ’S OFFICE REGARDING THIS NOTICE. If you have any questions about the settlement, you may contact Lead Counsel at the address listed above or by an e-mail to Lead Counsel at pfizerclaims@rgrdlaw.com. Lead Counsel also maintains a website with copies of pleadings and other documents filed in the Litigation at www.pfizersecuritiessettlement.com.

DATED: March 16, 2015

BY ORDER OF THE COURT
UNITED STATES DISTRICT COURT
SOUTHERN DISTRICT OF NEW YORK